Supernus Provides Regulatory Update for SPN-830 : vimarsana.com

ROCKVILLE, Md., April 08, 2024 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ...

Related Keywords

Timothyc Dec , Peter Vozzo , Jacka Khattar , Jack Khattar , Supernus Pharmaceuticals Inc , Nasdaq , Exchange Commission , Drug Administration , Securities Exchange , Company New Drug Application , Complete Response Letter , New Drug Application , Supernus Pharmaceuticals , Private Securities Litigation Reform Act , Securities Exchange Act , Senior Vice President ,